Initiator Pharma A/S
Clinical-stage firm developing drugs for nervous system disorders like ED & trigeminal neuralgia.
INIT | ST
Overview
Corporate Details
- ISIN(s):
- DK0060775872
- LEI:
- 213800DFI4I1A5RVKB59
- Country:
- Denmark
- Address:
- OLE MAALØES VEJ 3, 2200 KØBENHAVN N
- Website:
- https://www.initiatorpharma.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Initiator Pharma A/S is a clinical-stage life science company developing innovative drugs for unmet medical needs within the central and peripheral nervous system. The company's core focus is the therapeutic modulation of monoamine neurotransmitters through proprietary reuptake inhibitors. Its pipeline includes five projects, with three in clinical development, targeting conditions such as erectile dysfunction (ED), particularly for patients unresponsive to current drug therapies, and trigeminal neuralgia.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Initiator Pharma A/S filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Initiator Pharma A/S
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Initiator Pharma A/S via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
